Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Invivyd (IVVD) Equity Ratio (2020 - 2025)

Invivyd posted quarterly Equity Ratio of 0.87 for Q4 2025, up 67.29% year-on-year from 0.52 in Q4 2024, and up 30.44% on a QoQ basis from 0.67 in Q3 2025.

Invivyd (IVVD) has 6 years of Equity Ratio data on file, last reported at 0.87 in Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio rose 67.29% year-over-year to 0.87; the trailing twelve-month figure through Dec 2025 stood at 0.87 (up 67.29% YoY), and the FY2025 full-year result was 0.87, up 67.29% from the prior year.
  • Equity Ratio for Q4 2025 stood at 0.87, up from 0.67 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.93 in Q1 2023 and bottomed at 0.36 in Q2 2021.
  • The 5-year median for Equity Ratio is 0.83 (2024), against an average of 0.72.
  • The widest annual swing landed in 2022, when Equity Ratio surged 335.57%; it then sank 42.72% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.9 in 2021, then advanced by 3.24% to 0.93 in 2022, then declined by 16.65% to 0.77 in 2023, then plunged by 32.66% to 0.52 in 2024, then surged by 67.29% to 0.87 in 2025.
  • The last three Equity Ratio figures came in at 0.87 (Q4 2025), 0.67 (Q3 2025), and 0.48 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 0.04
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 0.42
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 0.73
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 0.77
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 0.21
10 Invivyd 208.38 Mn -18.31 Mn - 0.87

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.87
Sep 30, 2025 0.67
Jun 30, 2025 0.48
Mar 31, 2025 0.52
Dec 31, 2024 0.52
Sep 30, 2024 0.51
Jun 30, 2024 0.79
Mar 31, 2024 0.83
Dec 31, 2023 0.77
Sep 30, 2023 0.90
Jun 30, 2023 0.89
Mar 31, 2023 0.93
Dec 31, 2022 0.93
Sep 30, 2022 0.89
Jun 30, 2022 0.86
Mar 31, 2022 0.83
Dec 31, 2021 0.90
Sep 30, 2021 0.92
Jun 30, 2021 -0.36
Dec 31, 2020 -0.56